Tavenier, Juliette
Rasmussen, Line Jee Hartmann
Tolstrup, Janne
Petersen, Janne
Sobocki, Jakob
Pisinger, Charlotta
Eugen-Olsen, Jesper
Gamst-Jensen, Hejdi
Article History
Received: 14 June 2022
Accepted: 15 November 2022
First Online: 17 November 2022
Competing interests
: J.E.O. is named inventor on patents on suPAR as a prognostic biomarker. The patents are owned by Copenhagen University Hospital Hvidovre, Denmark. J.E.O. is a shareholder, CSO, and co-founder of ViroGates A/S, Denmark. The other authors declare no competing interests.